Medtronic Raised Its Outlook as Heart Devices Accelerate, But Can the Momentum Last? Medtronic's fiscal 2027 outlook has received a boost following a robust quarter in cardiovascular devices.
The company's confidence is palpable, and investors are taking note. However, beneath the surface, concerns remain about the sustainability of this growth.
The key driver of Medtronic's success is its pulsed field ablation products, which have seen an 88% increase in sales.